To evaluate sleep-wake disturbances in sedentary community-dwelling elderly adults with functional limitations. DESIGN: Cross-sectional. SETTING: Lifestyle Interventions and Independence in Elder (LIFE) Study. PARTICIPANTS: Community-dwelling persons (mean age 78.9) who spent fewer than 20 min/wk in the previous month engaged in regular physical activity and fewer than 125 min/wk of moderate physical activity, and had a Short Physical Performance Battery (SPPB) score of <10 (N = 1,635). MEASUREMENTS: Mobility was evaluated according to 400-m walk time (slow gait speed defined as <0.8 m/s) and SPPB score (≤7 defined moderate to severe mobility impairment). Physical inactivity was defined according to sedentary time, as a percentage of accelerometry wear time with activity of <100 counts/min; participants in the top quartile of sedentary time were classified as having a high sedentary time. Sleep-wake disturbances were evaluated using the Insomnia Severity Index (ISI) (range 0-28; ≥8 defined insomnia), Epworth Sleepiness Scale (ESS) (range 0-24; ≥10 defined daytime drowsiness), Pittsburgh Sleep Quality Index (PSQI) (range 0-21; >5 defined poor sleep quality), and Berlin Questionnaire (high risk of sleep apnea). RESULTS: Prevalence rates were 43.5% for slow gait speed and 44.7% for moderate to severe mobility impairment, with 77.0% of accelerometry wear time spent as sedentary time. Prevalence rates were 33.0% for insomnia, 18.1% for daytime drowsiness, 47.8% for poor sleep quality, and 32.9% for high risk of sleep apnea. Participants with insomnia had a mean ISI score of 12.1, those with daytime drowsiness had a mean ESS score of 12.5, and those with poor sleep quality had a mean PSQI score of 9.2. In adjusted models, measures of mobility and physical inactivity were generally not associated with sleep-wake disturbances, using continuous or categorical variables. CONCLUSION: In a large sample of sedentary community-dwelling elderly adults with functional limitations, sleep-wake disturbances were prevalent but only mildly severe and were generally not associated with mobility impairment or physical inactivity. J Am Geriatr Soc 62:1064-1072, 2014.
S leep-wake disturbances are prevalent in older persons and are associated with adverse outcomes. In two large studies of community-dwelling elderly adults, 1,2 prevalence rates for insomnia symptoms and daytime napping ranged from 43% to 50% and 25% to 46%, respectively. It is likely that the mechanisms underlying these high rates of sleep-wake disturbances include age-related increases in the prevalence of sleep apnea and multimorbidity, as well as age-related declines in sleep physiology. [3] [4] [5] [6] [7] [8] Adverse outcomes associated with sleep-wake disturbances include reductions in driving capacity and cognition, cardiovascular disease, depression, falls, institutionalization, and death. 1, 2, 8, 9 In older persons, risk factors for having sleep-wake disturbances may also include mobility impairment and physical inactivity. 2, 4, 10, 11 In the Established Populations for Epidemiologic Studies of the Elderly (EPESE), for example, physical disability at follow-up (dependency in activities of daily living or inability to walk up and down stairs or half a mile without help) increased the likelihood of incident insomnia by 109%. 4 In the 2003 National Sleep Foundation poll, older persons who reported mobility disability (very difficult or unable to walk half a mile or up and down a flight of stairs without help) had twice the prevalence or more of insomnia, daytime drowsiness, and history of sleep apnea as those with normal mobility. 2 In the Wisconsin Sleep Cohort Study, low physical activity was cross-sectionally associated with greater severity of polysomnography-confirmed sleep apnea. 11 These prior studies, although based on population-derived samples, had limitations because mobility and physical activity were evaluated according to self-report or because insomnia and daytime drowsiness were established using single-item questions, rather than validated questionnaires such as the Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), and Pittsburgh Sleep Quality Index (PSQI). [12] [13] [14] The Lifestyle Interventions and Independence for Elders (LIFE) Study is a randomized controlled trial designed to compare a physical activity program with a successful-aging health education program in 1,635 community-dwelling older persons. 15, 16 Participants were limited to persons aged 70 to 89 who reported sedentary status and had lower extremity functional limitations but were otherwise not disabled. 16 At the baseline evaluation, the study protocol included objective measures of mobility and physical activity, as well as sleep-wake questionnaires such as the ISI, ESS, and PSQI. [12] [13] [14] [15] [16] As a validated measure of the clinical risk of having sleep apnea, the Berlin Questionnaire (BQ) was also administered. 17 Because enrollment criteria included sedentary status and lower extremity functional limitations, it was postulated that sleep-wake disturbances would be prevalent in the LIFE Study. Moreover, it was postulated that performance-based mobility and habitual physical inactivity would be cross-sectionally associated with sleep-wake disturbances and that other known risk factors for sleepwake disturbances (e.g., female sex, obesity, depressive symptoms, multimorbidity, medications, and health status) would modify these associations. 1, 2, [4] [5] [6] [7] [8] 18 The results of this work may further inform the importance of mobility impairment and sedentary behavior as potential risk factors for sleep-wake disturbances in older persons.
METHODS

Study Population
The LIFE Study is a multicenter randomized controlled trial comparing a moderate-intensity physical activity program with a successful-aging health education program in 1,635 nondisabled, community-dwelling persons aged 70 to 89. 15 The assembly of this cohort has been described in detail elsewhere. 16 In brief, eligibility criteria included low physical activity, defined as spending fewer than 20 min/ wk in the previous month getting regular physical activity and reporting fewer than 125 min/wk of moderate physical activity on the modified 18-item Community Healthy Activities Model Program for Seniors questionnaire, 19 and lower extremity functional limitations, defined as a Short Physical Performance Battery (SPPB) score of <10 20,21 but able to complete a 400-m walk test (400MWT) in 15 minutes without sitting, leaning, or the help of another person. The institutional review boards of participating centers approved all study procedures. The present study reports on the baseline evaluation of LIFE participants.
Demographic and Clinical Characteristics
Baseline characteristics included age, sex, ethnicity, body mass index (BMI, kg/m 2 ), cognition, depressive symptoms, smoking status, medical conditions, medications, caffeine or energy drink use, and health status. Cognition was evaluated using the Modified Mini-Mental State Examination (3MSE), 22 with scores <89 indicating possible cognitive impairment. 15 Depressive symptoms were evaluated using the Center for Epidemiologic Studies Depression Scale (CES-D), with scores of 16 or greater indicating high levels of depressive symptoms. 23 Medical conditions were selfreported physician-diagnosed and were selected based on their known association with sleep-wake disturbances, including hypertension, coronary artery disease, heart failure, stroke, chronic lung disease (asthma, chronic bronchitis, emphysema, chronic obstructive pulmonary disease), diabetes mellitus, and symptomatic arthritis.
1,2,4,6-8 Medications were defined in two ways: total number of prescription medications and whether participants reported the use of a prescription medication with a potential central nervous system (CNS) effect (anticonvulsant, antidepressant, antihistamine, antipsychotic, barbiturate, benzodiazepine, muscle relaxant, or an opiate). Polypharmacy was defined as the use of four or more medications. 24 Caffeine or energy drink use was defined as daily consumption of at least two cups or cans of caffeinated beverages, such as soda, energy drinks, coffee, tea, iced coffee, or iced tea. 25 To assess health status, participants were asked, "Would you say your health in general is excellent, very good, good, fair, or poor?"
Mobility Impairment and Physical Inactivity
Mobility measures included the 400MWT and SPPB. The 400MWT was completed at the participant's usual walking pace over a 40-m course. Slow gait speed was defined as <0.8 m/s, a threshold that has been associated with adverse health outcomes, 26 including mortality. 27 The SPPB is a summary performance measure consisting of time to walk 4 m at usual pace, time to complete five chair stands, and three increasingly difficult standing balance maneuvers. 28 A SPPB score of 7 or less was selected to identify participants as having moderate to severe mobility impairment, whereas scores of 8 and 9 represented mild mobility impairment. 15, 20, 21, 28 Prior work has shown that SPPB scores of 7 to 9 and <7 are associated with a 80% and 390%, respectively, greater risk of mobility-related disability than a SPPB score of 10 or greater. 20 Physical inactivity was established using accelerometry (ActiGraph GT3X and ActiLife software, version 5; ActiGraphTM LLC, Pensacola, FL) over a planned 7-day monitoring period. Online Appendix S1 provides a detailed description of the accelerometry data collection and processing. Briefly, after dressing each morning, participants placed the accelerometer on their right hip (waistline belt) and removed it just before going to bed at night. The measure of interest was sedentary time, defined as percentage of accelerometry wear time with activity of <100 counts/min (approximated sitting time), 29 averaged across at least 5 days of monitoring, including 10 hours on each day. (This amount of wear time correlates well with 3 weeks of wear time.) 30 Participants who were in the top quartile were classified as having high sedentary time.
Of the 1,635 LIFE participants, all completed the 400MWT and SPPB evaluation, and 1,173 (71.7%) met the requisite accelerometer wear time definition.
Sleep-Wake Disturbances
Sleep-wake disturbances were defined using the ISI, ESS, PSQI, and BQ.
The ISI is a seven-item questionnaire based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for insomnia. 12 The response to each item is scored on a scale from 0 to 4, yielding an ISI score ranging from 0 to 28, with higher scores signifying more-severe symptoms. Based on prior work, an ISI score of 8 or greater established a diagnosis of insomnia. 12 The ESS measures the chance of dozing on a scale of 0 to 3 as experienced during eight different activities. 13 The ESS score ranges from 0 to 24, with higher scores signifying more-severe symptoms. Two frequently cited thresholds for establishing daytime drowsiness are ESS scores of 10 and 11. 13, [31] [32] [33] [34] [35] An ESS score of 10 or greater was chosen to establish clinically meaningful daytime drowsiness because the National Sleep Foundation (NSF) has used this score, and it is associated in older persons with other measures of daytime drowsiness, as well as hypertension, stroke, frailty, and driving capacity. [31] [32] [33] [34] [35] The PSQI provides a comprehensive evaluation of sleep-wake disturbances over the prior month.
14 It includes seven subscales: subjective sleep quality, sleep latency, sleep duration, habitual sleep disturbances, use of sleep medications, and daytime dysfunction. Each subscale is weighted equally on a scale from 0 to 3, with the total PSQI score ranging from 0 to 21; the higher the score, the worse the sleep quality. Based on prior work, a PSQI score of >5 indicated poor sleep quality. 14 The BQ consists of three categories that evaluate the clinical features of obstructive sleep apnea (OSA). 17 Category I includes five items related to snoring and witnessed apneas, with a maximum of six points. Category II includes three items related to a history of fatigue and drowsiness, with a maximum of three points. Category III includes a history of hypertension or BMI of 30.0 kg/m 2 or greater, with scoring based on a yes/no response (no points assigned). A positive response for Categories I and II is noted if either scores at least two points, whereas a positive response for Category III requires a yes response to a history of hypertension or BMI of 30.0 kg/m 2 or greater. Participants were then classified as having high risk of OSA if they had positive responses in at least two of the three categories, with all others classified as low risk. 17 Because Category III does not have an assigned point score, the BQ was evaluated only as a categorical variable.
Of the 1,635 LIFE participants, 1,578 (96.5%) completed the ISI, 1,589 (97.2%) completed the ESS, 1,620 (99.1%) completed the PSQI, and 1,611 (98.5%) completed the BQ. There were also participants who partially completed their sleep-wake questionnaire, but their scores nonetheless met criteria for a sleep-wake disturbance, including 32 participants with an ISI score of eight or greater, two with an ESS score of 10 or greater, nine with a PSQI score >5, and two with a BQ that met criteria for high risk of OSA. Participants who met criteria for a sleep-wake disturbance based on a partially completed sleep-wake questionnaires were included in the analysis of categorical variables but excluded from the analysis of continuous variables, including calculation of mean values.
Statistical Analysis
The baseline demographic and clinical characteristics of study participants were first summarized as means and standard deviations or as counts and percentages. Similarly, measures of mobility, physical inactivity, and sleepwake disturbances were also summarized using continuous and categorical variables. The degree of correlation of the measures of physical inactivity and mobility impairment was also evaluated.
Next, in unadjusted and adjusted models, continuous measures of mobility and physical inactivity were regressed on continuous measures of sleep-wake disturbances, yielding coefficients of determination (R 2 percentage values). The R 2 percentage values quantified the total variability in sleep-wake disturbances that measures of mobility and sedentary time explained. P-values for each predictor were also calculated for the explained variation of the predictor as the last variable in the model.
Similarly, but using categorical variables, the associations between slow gait speed, moderate to severe mobility impairment, and high sedentary time and sleep-wake disturbances (insomnia, daytime drowsiness, poor sleep quality, and high risk of sleep apnea) were evaluated by calculating odds ratios in unadjusted and adjusted logistic regression models.
Covariates in the adjusted models included age, sex, race, BMI, 3MSE score, level of depressive symptoms, number of medical conditions, polypharmacy, CNS-based medication, use of caffeine or energy drinks, and health status. Because the amount of missing data was small for the covariates that were adjusted for in these models (Table 1) , analyses were fit to the subset of cases with complete data.
Last, the potential effect modification of the associations between mobility and physical inactivity and poor sleep quality was also assessed in a series of exploratory analyses. In particular, using logistic regression models, interactions were evaluated by crossing known risk factors for sleep-wake disturbances, including female sex, obesity (BMI ≥ 30), high level of depressive symptoms (CES-D ≥ 16), multimorbidity (≥2 medical conditions), polypharmacy (≥4 medications), use of a CNS-based medication, and poor health status, 1, 2, 4, [6] [7] [8] 18 with slow gait speed, moderate to severe mobility impairment, and high sedentary time. In these analyses, the selected outcome was poor sleep quality, because it is based on the PSQI, which provided a broad assessment of sleep-wake disturbances. (The PSQI evaluates insomnia symptoms, daytime drowsiness, and risk factors for sleep apnea.) 14 In the logistic regression models, the covariates included age, sex, race, BMI, 3MSE, level of depressive symptoms, number of medical conditions, polypharmacy, CNS-based medication, use of caffeine or energy drinks, and health status, except when the covariate was the effect modifier of interest.
All statistical analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC), assuming a Type I error rate of 0.05. Table 1 summarizes demographic and clinical characteristics. The mean age was 78.9; 67.2% were female, and The results of the Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), and Pittsburgh Sleep Quality Index (PSQI) questionnaires were reported in three ways: overall mean score, number of participants who had a sleep-wake disturbance, and mean score for the subgroup who had a sleep-wake disturbance. The Berlin Questionnaire (BQ) was reported only as a dichotomous variable. c Sample sizes for the ISI, ESS, and PSQI also varied according to the reported analysis. In particular, if the ISI, ESS, or PSQI score met criteria for a sleep-wake disturbance, but the questionnaire was otherwise incomplete, a sleep-wake disturbance was still established (reported as a categorical variable), whereas the continuous score was considered missing (not included in the calculation of mean values). For example, the sample size was 1,610 for estimating the frequency of insomnia (ISI ≥8) but only 1,578 when calculating the overall mean ISI. Similarly, the calculation of the mean ISI among the 532 participants who had insomnia (ISI ≥8) was based on a sample size of only 500 participants. d Range 0 to 28; higher scores signifying more-severe insomnia. e Ranges 0 to 24; higher scores signifying more-severe daytime drowsiness. f Range 0 to 21; higher scores signifying worse sleep quality. g Required ≥2 positive categories on the BQ. 48 .1% (former and current smokers). Possible cognitive impairment (3MSE score <89) were identified in 26.9% of participants and high levels of depressive symptoms (CES-D score ≥16) in 19.6%. The mean number of medical conditions (known to be associated with sleep-wake disturbances) was 1.5, with the five most prevalent being hypertension (71.0%), diabetes mellitus (25.4%), symptomatic arthritis (19.6%), chronic lung disease (15.6%), and coronary artery disease (7.9%). Participants used an average of 5.4 medications, with 70.3% identified as having polypharmacy and 40.1% as using a CNS-based medication. Caffeine or energy drink use was also prevalent, reported by 79.6% of participants. Only 16.6% reported poor health status. Table 2 summarizes mobility, physical inactivity, and sleep-wake disturbances, using continuous and categorical variables. Slow gait speed was present in 43.5% of participants and moderate to severe mobility impairment in 44.7%, with accelerometer-based activity averaging 77.0% as sedentary time. The correlation was only À0.26 between sedentary time and gait speed and À0.17 between sedentary time and SPPB score, indicating that sedentary time and measures of mobility are different constructs. Sleep-wake disturbances were also common, with 33.0% of participants having insomnia, 18.1% daytime drowsiness, 47.8% poor sleep quality, and 32.9% high risk of sleep apnea. Nevertheless, as a group, LIFE participants had mean values for the ISI (5.8), ESS (6.1), and PSQI (5.9) that were less than one third of maximum available scores (28, 24, and 21, respectively). Moreover, in LIFE participants who met criteria for insomnia, daytime drowsiness, and poor sleep quality, the respective mean scores for the ISI (12.1), ESS (12.5), and PSQI (9.2) were only mildly abnormal. Tables 3 and 4 show the cross-sectional associations between mobility and physical inactivity and sleep-wake disturbances using continuous and categorical variables. As shown in Table 3 , the continuous measures of mobility and sedentary time explained <1% of the total variability in continuous measures of sleep-wake disturbances. Similarly, but using categorical variables, Table 4 showed that the adjusted odds ratios (ORs) for associations between impaired mobility and physical inactivity and sleep-wake disturbances were generally close to 1.0 and not significant. Table 5 presents exploratory results for the crosssectional associations between mobility impairment and high sedentary time and poor sleep quality according to several potential effect modifiers. In adjusted models, the most significant interaction was between slow gait speed and multimorbidity (association between slow gait speed and poor sleep quality: ≥2 medical conditions, adjusted OR (aOR) = 1.29, 95% confidence interval (CI) = 0.94-1.78); <2 medical conditions, aOR = 0.71, 95% CI = 0.53-0.96 (interaction: P < .01). A significant interaction was also seen between obesity and poor sleep quality 
RESULTS
DISCUSSION
In a large sample of sedentary community-dwelling elderly adults with functional limitations (LIFE Study), it was found that slow gait speed (43.5%) and moderate to severe mobility impairment (44.7%) were prevalent and that a high proportion of accelerometer-based activity (77.0%) was spent as sedentary time. Similarly, sleepwake disturbances were prevalent, including insomnia (33.0%), daytime drowsiness (18.1%), poor sleep quality (47.8%), and high risk of sleep apnea (32.9%). Nonetheless, using continuous or categorical variables, mobility and physical inactivity were not associated with sleepwake disturbances.
LIFE participants had prevalent risk factors for sleepwake disturbances, including female sex, obesity, smoking ) values by the corresponding explanatory variable (e.g., in adjusted models, the 400-m walk time explained only 0.247% of the variability in the Insomnia Severity Index (ISI). e Adjusted for age, sex, race, body mass index, Modified Mini-Mental State Examination score, level of depressive symptoms, number of medical conditions, polypharmacy, central nervous system-based medication, use of caffeine or energy drinks, and health status (Methods). f Percentage of accelerometer wear time with activity <100 counts/min averaged across days. Limited to participants with ≥5 days of wear time and ≥10 hours each day.
history, depressive symptoms, polypharmacy, and use of caffeine or energy drinks. 1, 2, 4, 8, 18, 25 These risk factors may have contributed to the high prevalence of sleep-wake disturbances in the LIFE Study, although LIFE participants as a group had only mild sleep-wake disturbances, as reflected by mean ISI (5.8), ESS (6.1), and PSQI (5.9) scores, which were less than one third of the maximum available scores (28, 24 , and 21, respectively). [12] [13] [14] Moreover, in LIFE participants who met criteria for insomnia, daytime drowsiness, and poor sleep quality, the respective mean scores for ISI (12.1), ESS (12.5), and PSQI (9.2) were only mildly abnormal. For example, mild, moderate, and severe insomnia are defined as an ISI of 8 to 14, 15 to 21, and 22 to 28, respectively, 12 whereas an ESS score of 16 or greater signifies high levels of daytime drowsiness. 13 Although the PSQI has not been previously described according to level of severity, an abnormal score ranges from 6 to 21, with higher scores signifying worse sleep quality.
14 Prior work has shown that greater multimorbidity, poorer health status, and physical disability (including mobility disability) are associated with sleep-wake disturbances. 2, 4, 8, 36, 37 Furthermore, the results of the LIFE Study suggested a potential interaction between multimorbidity and poor mobility for the outcome of poor sleep quality (≥2 medical conditions significantly increased the association between slow gait speed and a PSQI score >5). Consequently, low levels of symptomatic multimorbidity may explain the mild severity of sleep-wake disturbances in the LIFE Study. In particular, LIFE participants had on average fewer than two medical conditions that are known to be associated with sleep-wake disturbances, 1,2,4,6-8,18 and only 16.6% of participants had poor health. In addition, an important exclusion criterion in the LIFE Study was mobility disability, including self-reported inability to walk across a room or inability to complete the 400MWT. 15, 16 The mild severity of sleep-wake disturbances in LIFE participants may also reflect their advanced age. In particular, although aging is associated with reductions in sleep physiology (e.g., reduced slow wave and rapid eye movement sleep), 5 the phenotype of sleep-wake disturbances may be milder with advancing age in at least three ways. First, chronic sleep loss and the consequent reduction in performance across wakefulness is more prevalent and severe in younger than older persons. 31, [38] [39] [40] Second, the importance of OSA may diminish with age. For example, OSA is associated with more-severe nocturnal hypoxemia and daytime drowsiness in younger than older persons, and OSA is associated with incident coronary heart disease in middle age but not in old age. 3, 6, 41 Third, by adjusting daytime activity patterns, older persons may alter the phenotype of sleep-wake disturbances. To illustrate, rates of drowsy driving were substantially higher in a national survey of drivers aged 18 to 29 (19.4%) than in a cohort of active older drivers aged 70 and older (5.1%). 31 It is likely that the different rates of drowsy driving reflected age-related driving patterns, with younger persons driving longer distances than older persons (42.3 vs 13.8 miles/d). 42 Driving a shorter distance attenuates the adverse effect of sleep-wake disturbances on driver alertness (two of the eight items of the ESS relate to drowsiness while in a motor vehicle). In light of the above discussion, the lack of associations between mobility and physical inactivity and sleepwake disturbances at the baseline visit of the LIFE Study may have been in part because the sleep-wake outcomes were only mild in severity. Despite these results, the longitudinal component of the LIFE Study may provide important insights into the associations between mobility and physical inactivity and sleep-wake disturbances, including the importance of effect modifiers. In particular, over an average course of 2.7 years, it is hypothesized that the LIFE physical activity program may reduce the incidence of sleep-wake disturbances more than a successful aging (SA) education program by improving mobility and physical inactivity, and that health status and depressive symptoms (among other factors) modify this effect. 4, 8, [43] [44] [45] [46] [47] The longitudinal component of the LIFE Study may also help clarify whether lack of mobility and physical inactivity have bidirectional associations with sleep-wake disturbances. Prior work, for example, has shown that depression and heart disease have bidirectional associations with sleep-wake disturbances. [47] [48] [49] Similarly, because of shared risk factors (e.g., depression or heart disease) or as a direct effect, it is hypothesized that insomnia and daytime drowsiness may lead to physical inactivity and deconditioning (reduced mobility), whereas physical inactivity and reduced mobility may adversely affect the homeostatic and circadian regulation of the sleep-wake cycle, increasing the risk of sleep-wake disturbances. 8 This and the earlier stated hypothesis will be tested when the longitudinal data in the LIFE Study become available.
13,42
Three limitations may have affected the present study. First, because the LIFE Study enrolled only sedentary individuals with functional limitations, the range of scores on measures of mobility and physical inactivity was constrained and probably attenuated the associations of interest. To illustrate, the LIFE Study had a mean time for the 400MWT of 510 seconds (8.5 minutes), yielding a mean gait speed of 0.78 m/s, whereas the Invecchiare in Chianti Study, which involved a representative sample of community-dwelling older persons, had a mean time for the 400MWT of 331 seconds (5.5 minutes), yielding a mean gait speed of 1.12 m/s. 50 Similarly, 44.7% of LIFE participants had an SPPB score of 7 or less, whereas a prior study found that only 10.0% of a representative sample of community-dwelling elderly adults (EPESE) had an SPPB score <7. 22 Second, although missing values were infrequent for mobility and sleep-wake measures, 28.9% of LIFE participants did not complete a minimum of 5 days of accelerometry. Nonetheless, these participants had a level of functional limitations similar to that of those who completed at least 5 days of accelerometry (mean SPPB scores of 7.2 AE 1.5 and 7.4 AE 1.6, respectively). Third, because symptom awareness decreases with age, 51 the ISI, ESS, and PSQI may be limited as indicators of severe sleepwake disturbances in older persons. Moreover, selfreported snoring and apnea have diminished predictive capacity for sleep apnea in older persons, potentially limiting the accuracy of the BQ. 52 To address these limitations, future studies will need to enroll older persons who have a broader range of mobility capacity and physical activity and implement an objective evaluation of sleep-wake disturbances (e.g., wrist actigraphy and polysomnography).
In conclusion, in a large sample of sedentary community-dwelling elderly adults with functional limitations (LIFE Study), sleep-wake disturbances were prevalent but only mildly severe and were not associated with mobility impairment or physical inactivity. The next step in this line of research is to evaluate changes in these variables over time when the longitudinal LIFE Study ends. Doing so may provide important insights regarding ongoing associations between mobility impairment and physical inactivity and sleep-wake disturbances and regarding the effects of physical activity on sleep-wake disturbances.
